Zenas BioPharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Zenas BioPharma, Inc. (ZBIO) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $66.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-03-16
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $66.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $36.00K.
- 2025-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $51.00K.
- 2025-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $77.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2025-12-31 | $66.00K 10-K · filed 2026-03-16 |
| 2025-09-30 | $36.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $51.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $77.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $134.00K 10-K · filed 2025-03-11 |
| 2024-09-30 | $258.00M 10-Q · filed 2024-11-12 |